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Abstract The innate immune system has evolved a
variety of sensing mechanisms to detect and counter
microbial invasion. These include the Toll-like receptor
(TLR), cytoplasmic, nucleotide binding oligomerization
domain (NOD)-like receptor and RIG-I-like helicase
(RLH) pathways. However, how the cell detects pathogen-
associated DNA to trigger host defense, including the
production of interferon, remains to be fully clarified.
Understanding these processes could have profound
implications into how we understand and treat a variety of
microbial-related disease, including viral-associated can-
cers, as well as autoimmune disorders. Recently, an
endoplasmic reticulum-associated molecule referred to as
STING (for stimulator of interferon genes) was isolated
and shown to be critical for regulating the production of
IFN in response to cytoplasmic DNA. Here, we review
recent discoveries relating to the detection of foreign DNA,
including the importance of the STING and inflammasome
pathways and the triggering of innate signaling processes.
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Host exposure to microbial pathogens such as viruses, bac-
teria, and fungi trigger the activation of innate immune
responses that stimulate early host defense mechanisms such
as the production of type I interferon (IFN), as well as
invigorate adaptive immune responses involving cytotoxic T
cell activity and antibody production [1–3]. The recognition
of pathogenic microbes and the triggering of the innate
immune cascade has become the subject of intense research
over the past few years. Key activators of innate immune
signaling pathways are now known to comprise pathogen-
derived nucleic acid such as microbial genomic RNA and
DNA (referred to as PAMPs—pathogen-associated molec-
ular patterns) [1]. Recent findings indicate that a number of
sensing systems have evolved in different cell types to detect
pathogen-derived nucleic acid. Cellular invasion, for
example by viruses, can directly trigger the production of
type I IFN, or conversely cells of the hematopoietic lineage,
such as macrophages and dendritic cells can engulf apoptotic
cell debris comprising viral antigen and nucleic acid and
produce IFN and other cytokines such as the interleukins,
which can result in a pro-inflammatory response [4, 5].
The pattern recognition receptors (PRRs) responsible for
sensing viral RNA have recently been isolated and have
been found to involve DExD/H box RNA helicases called
retinoic acid inducible gene I (RIG-I), melanoma differ-
entiation-associated gene 5 (MDA5), and LGP2 [6, 7].
These helicases are responsible for the production of IFN
in all cell types, in response to RNA virus infection, aside
from plasmacytoid dendritic cells (pDCs) [8, 9]. Helicase
interaction with viral RNA induces the recruitment of a
molecule referred to as IPS-1 (also known as VISA, Cardif
or MAVS) and TRAF3 and leads to the activation of
mitogen activated protein (MAP) kinases, the IKK-related
kinases, TBK1 (TANK binding kinase 1) and IKK-I (IjB
kinase I) [10–13]. These kinases activate the transcription
factors NF-jB, activator protein-1 (AP1) and interferon
regulatory factor-3 (IRF3), which translocate into the
nucleus and bind to and activate the IFNb promoter [1–3].
IFN is secreted, binds to the type I IFN receptor (IFNAR)
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in an autocrine or paracrine fashion and activates the Jak/
STAT pathway to initiate the production of numerous
IFN-inducible genes which exert potent anti-viral activity
through mechanisms that in many cases remain to be fully
clarified [14].
In pDCs, another mechanism has evolved to trigger the
production of type I IFN in response to RNA virus infec-
tion, which is essential for protection of the host. This
involves the Toll-like receptor (TLR) pathway and spe-
cifically, TLR7, which associates with MyD88 (myeloid
differentiation primary response gene 88) and members of
the IRAK (interleukin-1 receptor associated kinase) and
TRAF family [2, 3]. These events rapidly and potently lead
to phosphorylation of IRF7, which, similar to IRF3,
translocates to the nucleus to activate the production of
type I IFN [9]. There are known to be approximately ten
human TLRs, the different members of which recognize a
variety of microbial PAMPs such as lipopolysaccharides
(TLR4) common on bacterial cell walls and viral dsRNA
(TLR3) that can similarly induce the production of IFN as
well as other cytokines in a variety of cell types [1–3].
Finally, microbial PAMPs can be recognized by the NLR
(nucleotide-binding domain leucine-rich repeat) family of
sensors that can activate NF-jB and caspase-1 and trigger
pro-inflammatory responses such as those involving pro-
duction of IL-1b. For example, the NLRs NOD1 and 2 are
known to recognize bacterial muramyl dipeptides to trigger
the activation of NF-jB [3, 15].
However, while significant progress has been made in
unraveling mechanisms responsible for recognizing bacte-
ria cell wall components and RNA viruses, somewhat less
is known about how microbial DNA is sensed by the cell
to trigger innate immune responses. This is of profound
interest since many pathogens such as cancer-causing
viruses, bacteria, fungus, and parasites comprise DNA
genomes, which are known to activate IFN production
[1–3]. Further, endogenous self-DNA may be responsible
for inadvertently activating our own innate immune path-
ways and mitigating autoimmune disease [5]. Recently a
molecule, referred to as STING (for stimulator of interferon
genes) was isolated that was shown to be pivotal to the
production of type I IFN by DNA, in numerous cell types,
including macrophages, DCs and fibroblasts [16, 17]. Here,
we review the involvement of STING in this process, as
well as illustrate what is presently known about innate
signaling pathways triggered by DNA.
TLR-dependent DNA sensing mechanisms
A well-characterized DNA sensing receptor responsible
for triggering innate immune responses is TLR9, which
contains leucine-rich repeat (LRR) motifs, a Toll/IL-1R
homology domain and is considered a type I integral
membrane glycoprotein [3, 18]. TLR9 recognizes CpG
(cytidine–phosphate–guanosine) DNA motifs that are
commonly found in bacteria and viruses, but which is rare
in vertebrates. Several studies using TLR9-deficient mice
have emphasized a role for TLR9 in host innate immune
responses against DNA viruses such as herpes simplex
virus [3, 19, 20]. TLR9 is mainly expressed in pDCs,
which, as mentioned, are a subset of DCs with a plasma-
cytoid morphology that produce IFN and cytokines in
response to CpG DNA or RNA viruses [3, 21]. However,
TLR9-deficient animals remain able to produce IFN fol-
lowing infection with DNA viruses, indicating the
existence of key TLR-independent mechanisms responsible
for activating DNA-mediated innate immune signaling
[20, 22, 23].
Unprocessed TLR9 localizes on the endoplasmic retic-
ulum (ER) in unstimulated pDCs. CpG DNA, internalized
via a clathrin-dependent endocytic pathway, moves to en-
dolysosomal compartments and associates with processed,
active TLR9 that has trafficked to these regions from the
ER [1–3, 24]. The trafficking of TLR9 is controlled by
UNC93B, a 12-membrane-spanning ER protein that
directly interacts with TLR9 [25, 26]. The proteolytic
cleavage of endolysosomal TLR9 is required for TLR9
activation in response to CpG DNA [24].
Upon recognition of CpG DNA in endosomes, TLR9
interacts with MyD88, which contains a TIR domain and a
death domain [1–3]. MyD88 interacts with IRAK-1
(IL-1R-associated kinase 1), IRAK-4, and IRF-7. This
event leads to recruitment of TRAF6 (TNFR-associated
factor 6), which activates the TAK1 (transforming growth
factor b-activated kinase 1), MAPK and ultimately NF-jB.
IRAK1 directly interacts with IRF7, and phosphorylates
the C-terminal region of IRF7, which is required for tran-
scriptional activity [1–3]. Recently, the rapamycin-
sensitive PI(3)K-mTOR-p70S6K pathway has also been
demonstrated as being important in regulating TLR9
activity [27].
DNA sensing pathways have been implicated in trig-
gering innate and adaptive immune pathways mediated by
plasmid-based vaccines. DNA-vector-based vaccines have
been investigated in strategies to induce immunity against
disease since they can be manufactured quickly and eco-
nomically [28]. However, DNA vaccines exhibit low
immunogenicity and so the enhancement of vaccine effi-
cacy has become a key objective in the development of
effective DNA vaccination protocols. Understanding the
mechanisms of DNA-dependent innate signaling may
therefore lead to improvements in effectiveness of DNA
vaccine procedures. It has become apparent, however, that
while TLR9 may indeed facilitate plasmid vaccination, a
number of studies have indicated that TLR9 is not essential
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for the induction of immune responses following DNA
immunization, again indicating that alternate DNA sensors
may be critically important for this process, as we shall
describe next [20, 22, 23]. However, the use of TLR
ligands has indeed been explored to improve the immu-
nogenicity of antigens used in vaccines. For example,
synthetic oligodeoxynucleotide (ODN) ligands, such as
CpG ODN for TLR9, have been reported to be a potent
adjuvant that enhances the strength of immunization.
Understanding these pathways may therefore lead to the
design of new adjuvant-related concepts to improve
vaccination strategies [28, 29].
It is noteworthy that DNA sensors such as TLR9 have
been implicated in the development of autoimmune dis-
eases such as systemic lupus erythematosus (SLE) [5, 15,
30]. It is considered that self-nucleic acids can act as
endogenous ligands for DNA receptors, which raise serum
levels of IFN and which correlate with both SLE disease
activity and severity. Thus, the unraveling of the DNA-
triggered innate immune signaling pathway may have
important implications in our understanding of autoim-
mune disease and could lead to the development of new





It became clear that cytosolic dsDNA derived from
invading microbes or host cells could be recognized by
TLR9-independent innate immune mechanisms to induce
type I interferon responses. For example, infection of
TLR9-deficient cells by DNA pathogens, such as herpes
simplex virus 1 (HSV1), or intracellular bacteria such as
Listeria monocytogenes, which is known to introduce DNA
into cytosol during infection, remained able to produce
type I IFNs [19, 20]. In addition, it has been reported that
DNA derived from engulfed apoptotic cells can induce
type I IFN expression in a TLR9-independent manner
[31, 32]. Finally, the transfection of TLR9-lacking cells
with synthetic double-stranded DNA (dsDNA) still resulted
in the induction of type I IFN [33, 34]. These observations
indicated the presence of a TLR-independent cytosolic
DNA-mediated innate signaling, the components of which
remained to be fully determined.
In an attempt to find key components of innate signal-
ing, we utilized an expression cloning strategy to identify
molecules that activated the IFN-b promoter [16]. This
strategy was based on determining which genes, when
overexpressed in 293T cells, were able to induce the
transcription of a luciferase gene, which was controlled by
the IFNb promoter. Adopting this procedure, we identified
a molecule referred to as STING (stimulator of interferon
genes), which we demonstrated was essential for cytosolic
DNA-mediated type I IFNs induction [16, 17]. STING, also
known as MITA/MPYS/ERIS, contained multi-putative
transmembrane regions in the amino terminal region, and
was found to predominantly localize in the endoplasmic
reticulum (ER) [16, 17, 35–37]. However, reports have also
indicated that STING may reside in the mitochondria,
although these studies were conducted using GFP-tagged
STING in overexpression studies, which may have affected
authentic localization. Overexpression of STING induced
the activation of both NF-jB and IRF3 to stimulate type I
IFN production [16, 35, 36]. Significantly, MEFs derived
from STING-deficient mice failed to induce type I IFNs in
response to infection with HSV-1 or Listeria monocytog-
enes, or transfection of interferon stimulatory DNA, ISD
(which comprises double-stranded 45-base-pair oligonu-
cleotides lacking CpG sequences) [16, 17]. Single-stranded
DNA did not robustly activate type I IFN induction via the
STING-regulatory pathway. Further investigation indicated
that STING was essential for intracellular DNA-mediated
activation of type I IFN in macrophages and in conven-
tional DCs [16, 17]. Importantly, both HSV-1 and Listeria
failed to induce type I IFN in DCs lacking STING either.
While STING was found to be critical for the induction of
type I IFN by intracellular DNA, it was not essential for
IFN production stimulated by transfected dsRNA (poly IC)
[16]. Further, while the production of type I IFN by
transfected DNA was ablated in the absence of STING,
IL1b production was not affected (which has been shown
to be AIM2-dependent, see below) [17]. Thus, STING
functions independently of AIM2 and is not critical for
inflammasome activation. Finally, our studies indicated
that STING was important for intracellular DNA-mediated
and HSV-1-activated type I IFN production in pDCs,
although the presence of TLR9 in these cells was found to
partially compensate for the loss of STING in response to
Listeria infection [17]. Given this, we observed that
STING-deficient animals, which were viable, rapidly suc-
cumbed to lethal HSV-1 infection compared to control
animals due to a lack of type I IFN production, which
enabled robust virus replication [17].
Importantly, we noticed that STING -/- animals were
also sensitive to negative-stranded virus infection, such as
VSV. This would indicate that STING may facilitate the
RIG-I pathway [16]. Immunoprecipitation experiments
demonstrated that STING may associate with RIG-I com-
plexes, but not with MDA5, perhaps explaining why loss of
STING had no significant effect on poly IC signaling (which
is largely mediated by MDA5) [1–3]. Our data indicated that
ER-associated STING likely associates in close proximity
DNA-activated innate immune signaling 1159
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with mitochondria associated with the ER (mitochondria
associated membrane- MAM) and perhaps peroxisome
complexes, both comprising IPS-1 required for RIG-I
function [17, 38]. Interestingly, STING exhibited significant
homology to flavivirus proteins such as yellow fever virus
(YFV), dengue virus (DV), and hepatitis C virus (HCV) NS4
proteins, which are known to reside in the ER. DV NS4 was
found to inhibit STING function [17]. Collectively, our data
indicates that STING is an important component of innate
immune signaling that governs not only intracellular DNA-
mediated IFN signaling but also RIG-I signaling, and may be
targeted by viruses for suppression.
Yeast two-hybrid and co-immunoprecipitation assays
showed that STING associated with SSR2/TRAPb, a
member of the translocon-associated protein (TRAP)
complex comprising four subunits (a–D) that facilitate
translocation of proteins into the endoplasmic reticulum
(ER) following translation [39, 40]. The translocon-asso-
ciated protein (TRAP) complex is known to associate with
the translocon, comprising three subunits, SEC61a,
SEC61b, and SEC61c [39, 41]. The translocon has been
shown to be important for protein folding and secretion.
RNA interference ablation of TRAPb or SEC61b expres-
sion was found to inhibit IFNb promoter activation
following STING overexpression in 293T cells [16].
Although it is not clear how signaling from STING/tran-
slocon complexes to IRF3/NF-jB occurs, evidence
indicates that the translocon may physically associate with
the exocyst, an evolutionally conserved octameric complex
that tethers secretory vesicles to membranes, and facilitates
protein synthesis and secretion [42, 43]. Recently, the
exocyst complex has been found to play a role in type I IFN
production. For example, Sec5, one of the components of
the exocyst complex, was found to recruit and activate
TBK1 which, as mentioned, is essential for IRF3/7 acti-
vation and type I IFN induction in response to RNA and
DNA pathogens [44]. Preliminary analysis indicated that
STING could associate with TBK1 and that RNAi ablation
of Sec5 reduced STING’s ability to activate the IFNb
promoter [16]. Thus, STING may link cytosolic
DNA-mediated signaling to TBK1 activation through
ER/translocon and exocyst interactions.
Following infection with HSV-1, STING was found to
rapidly translocate from the ER, through the Golgi to a
distinct perinuclear region, by mechanisms that presently
remain unclear [17]. TBK1 was found to similarly traffic in
response to HSV-1 infection, in a STING-dependent
manner, and likely such complexes may be required for the
activation of transcription factors such as IRF3 and 7 [17].
The endosomal compartments that comprise STING and
TBK1 following trafficking in response to intracellular
DNA remain to be fully characterized. However, the
translocation process was found to involve autophagy-
related gene 9a (Atg9a), and may involve STING ubiqui-
tination [35, 45]. Thus, the translocon and STING
trafficking to perinuclear endosomal compartments appear
necessary for the stimulation of innate immune pathways
involving the production of type I IFN, at least in response
to intracellular DNA.
Finally, it is noteworthy that previous work has
shown the importance of TBK-1 in stimulating plasmid
DNA-based immune responses. Plausibly, TBK1-depen-
dent pathways are triggered by intracellular plasmid
B-form DNA, which augments immune responses by
stimulating type I IFN and NF-jB-dependent pathways
[46, 47]. Since we observed that STING functions
upstream of TBK-1 and is required for TBK-1 activity in
response to intracellular DNA, we investigated whether
STING was important for the adjuvant effects of plasmid
DNA. This study confirmed that STING is indeed required
for effective DNA-mediated adaptive immune responses,
such as those stimulated by plasmid DNA vaccination as
well DNA virus infection such as with vaccinia virus [17].
Thus, the stimulation of STING-regulated pathways may
provide a mechanism to augment DNA-based plasmid
immunization strategies in the future.
While STING exhibits a number of putative trans-
membrane motifs, there do not appear to be any predicted
DNA-binding motifs in this ER-resident molecule, sug-
gesting that STING itself is unlikely to associate directly
with DNA. However, a number of molecules have been
reported to function as DNA sensors in the cell. For
example, DAI [DNA-dependent activator of IRFs, also
referred to as Z DNA binding-binding protein-1 (ZBP-1)]
has been identified as a cytosolic DNA receptor to induce
type I IFNs, at least in L929 cells [48]. Nevertheless, pri-
mary cells derived from DAI-deficient mice induce type I
IFN normally in response to cytosolic DNA. DAI-deficient
mice are also able to elicit an immune response to DNA-
based vaccines, collectively suggesting the existence of
alternate DNA sensors [46]. In this light, IFI16, a PYHIN
protein similar to AIM2, has also been implicated in
functioning as a cytoplasmic DNA sensor to induce IFN
[49]. This activity was shown to be STING-dependent. The
examination of IFI16 null mice may additionally empha-
size the importance of IFI16 in innate immune signaling.
Finally, the importance of high-mobility group box
(HMGB) proteins in facilitating nucleic-acid-dependent
innate immune signaling has been reported, emphasizing
the complexity of DNA sensing pathways in the cell [50].
Cytosolic DNA-mediated RNA polymerase
III/RIG-I/IPS-1-dependent innate signaling
Recent studies have also demonstrated the existence of a
novel cytosolic DNA sensing mechanism that is able to
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induce type I IFN in a DNA-dependent RNA polymerase
III manner [51, 52]. Transfected Poly(dA:dT) (synthetic
AT-rich dsDNA), but not other types of DNA including
poly(dG:dC) (synthetic GC-rich dsDNA), calf thymus
DNA, PCR fragments, or plasmid DNA, were capable of
producing dsRNA containing 50 triphosphate, which acti-
vated RIG-I/IPS-1-dependent innate signaling [51, 52].
RNAi abrogation of POL3RF, a component of RNA
polymerase III, or pharmacological inhibition of RNA
polymerase III, was found to inhibit production of dsRNA
from poly(dA:dT) [51, 52]. RIG-I recognizes 50 triphos-
phate RNA species, and interacts with IPS-1, an essential
adaptor molecule for RNA-inducing innate immune sig-
naling [6, 10–13, 53, 54]. IPS-1 activates both NFjB and
IRF-3 through FADD/RIP1 and TBK1, respectively [10–
13, 55]. As we have mentioned, STING also appears to be
involved in RIG-I/IPS-1-mediated signaling. However,
STING-deficient cells still remain partially able to produce
some IFNb in response to infection with negative-stranded
RNA viruses such as Sendai virus (SV) and VSV [16].
Moreover, while IFNb production mediated by ISD, HSV-
1, Listeria, or transfected plasmid DNA were completely
abrogated in STING-deficient MEFs, such cells produced
reduced but detectable amounts of IFNb after transfection
with poly(dA:dT) [17]. These observations indicate that
AT-rich DNA may induce both STING-dependent and
STING-independent RNA polymerase III/RIG-I/IPS-1-
regulated innate immune signaling pathways.
Cytosolic DNA-mediated inflammasome-dependent
innate signaling
It has been demonstrated that cytosolic DNA also triggers
TBK1-independent inflammasome-dependent innate
immune signaling [15, 56–59]. NALP3 (NACHT-leucine-
rich repeat-PYD containing protein 3), also known as
cryopyrin, recognizes Adenovirus infection and activates
ASC (apoptosis-associated speck-like protein containing a
caspase recruitment domain)/caspase-1-mediated secretion
of IL-1b [59]. Recently, four different groups identified
the HIN-200 family member, AIM2 (absence in melanoma
2), as the cytoplasmic dsDNA sensor that activates ASC/
caspase-1-mediated secretion of IL-1b [15, 56–59].
Importantly, AIM2 inflammasome is essential for caspase-
1 activation but completely dispensable for type I IFNs
production in response to cytosolic dsDNA, indicating
cytosolic DNA-mediated AIM2 inflammasome-dependent
signaling is distinct from type I IFNs-dependent innate
signaling. As mentioned above, activation of the inflam-
masome and the production of IL-1b by intracellular DNA
appear to be STING-independent. Thus, different DNA
sensors exist to trigger pro-inflammatory or type I IFN
production in response to infection.
DNA sensing mechanisms and autoimmunity
Type I IFN is an essential factor for host defense against
evading pathogens, but inappropriate production of type I
IFN leads to autoimmune diseases such as SLE, as men-
tioned earlier [60]. In eukaryotes, localization of self-DNA
is restricted to the cell nucleus and mitochondria, thereby
sequestering self-DNA from cytoplasmic DNA sensing
mechanisms, which may activate pro-inflammatory cyto-
kine pathways. Cellular DNases eliminate aberrant self-
DNA found in apoptotic bodies, extracellular space,
cytosol, and endosomes. Several studies have shown that
defective clearance of self-DNA leads to inappropriate
activation of type I IFNs production through a TLR-inde-
pendent innate immune signaling, which is tightly linked to
autoimmune diseases. For example, DNase I deficiency or
mutations are associated with lupus-like syndrome in mice
and humans [61, 62]. In addition, DNase II-deficient mice
have shown the accumulation of incompletely digested
DNA, which causes TLR-independent type I IFNs pro-
duction, inflammatory responses, and early death, which
are linked to autoimmune disease like chronic polyarthritis
[63]. Crossing susceptible mice with mice deficient in
the type I IFN receptor abrogated lethality, indicating the
importance of excessive IFN production in pathogenesis
[63].
Recently, several studies have reported that Trex1,
30-repair exonuclease 1, regulates DNA homeostasis and its
deficiency is linked to autoimmune diseases [64–66].
Mutations in the human Trex1 gene cause SLE and AGS
(Aicardi-Goutieres syndrome) [64, 65]. In addition, it has
been shown that Trex1-deficient mice develop lethal
autoimmunity via elevated production of type I IFNs and
auto-antibodies [66]. Interestingly, genetic ablation of
IRF3 or IFNR rescued Trex1-deficient mice from mortal-
ity, suggesting IRF3-dependent IFN production was linked
to autoimmune symptom in Trex1-deficient mice [66].
ssDNA derived from endogenous retroelements accumu-
lated in cells derived from Trex1-deficient mice [66].
Collectively, these observations suggest that Trex1 is
required for the prevention of autoimmunity that would
otherwise develop during the activation of the cytosolic
DNA-mediated innate immune signaling by cell-intrinsic
substrates [66].
As described, TLR9 also recognizes self-DNA and
induces type I IFNs. Several studies have suggested that the
specialized localization of TLR9 is required for preventing
recognition of self-DNA. For example, human DNA
associated with LL37, an antimicrobial peptide produced in
the skin of patients with psoriasis, is retained in early
endosomes in pDC and facilitates type I IFN induction
through the activation of TLR9. In addition, anti-DNA
antibodies, found in serum of patients with systemic lupus
DNA-activated innate immune signaling 1161
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erythematosus (SLE), bind self-DNA and induce type I
IFN via a cooperative interaction between TLR9 and CD32
in pDC [67]. Moreover, it has been shown that chimeric
TLR9, which localizes to the cell surface, can respond to
synthetic TLR9 ligands but not to viral DNA, suggesting
intracellular localization of TLR9 is required for prevent-
ing to recognize self-DNA [68].
Concluding remarks
While significant progress had been made into unraveling
TLR9-dependent DNA recognition systems, little was
known regarding cytosolic DNA-mediated innate immune
signaling. However, recent studies have gradually shed
light on the molecular mechanisms of intracellular
DNA-mediated inflammatory responses involving AIM2
production of IL-1b as well as STING controlled
DNA-mediated IFN production. In the latter case, the
triggering of type I IFN production in response to select
DNA viruses as well as intracellular bacteria appears
STING-dependent [16, 17]. However, STING is also
required for effective type I production in response to
certain RNA virus infection such as VSV and Sendai virus.
Given these observations, it will be of interest to evaluate
the importance of STING in stimulating host defenses
Fig. 1 DNA-mediated activation of innate immune signaling.
a TLR9-dependent innate immune signaling. TLR9 localizes in the
ER and interacts with UNC-93B, which mediates TLR9 translocation.
Upon stimulation of DNA-containing CpG motifs (CpG DNA)
including viral genome, TLR9 traffics from ER to endosome to
contact CpG DNA, and recruits a signaling complex consisting of
MyD88, IRAK4, and TRAF6. TRAF6 in turn activates TAK1, and
TAK1 subsequently activates MAPK and the IKK complex (IKKa,
IKKb, and IKKc) to activate NF-jB. NF-jB and MAPK regulates
inflammatory cytokines expression. IRAK4 activates TRAF3 and
IRAK1, which catalyze IRF7 phosphorylation and induce type I IFNs
expression. b Cytosolic DNA-mediated innate immune signaling.
Cytosolic AT-rich dsDNA is recognized by RNA PolIII and
transcribed into 50 triphosphate RNA, which activates RIG-I/IPS-1
signaling. IPS1 interacts with FADD/RIP1, which activate NF-jB.
IPS-1 also activates TBK1 which phosphorylates IRF-3 and induces
type I IFNs expression. AT-rich dsDNA or non-AT-rich dsDNA is
recognized by unknown receptor, and activate STING-dependent
signaling. STING localizes in the ER with translocon complex
(TRAPb, Sec61), and activate Sec5/TBK1 to induce type I IFNs.
STING also activates NF-jB to induce pro-inflammatory cytokines.
dsDNA also activates AIM2/ASC/Caspase-1 inflammasome pathway
to activate IL-1b
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against other types of DNA pathogens including parasites
such as malaria. Key issues that remain to be elucidated
also include the identification of cytosolic DNA receptor(s)
which activate the STING pathway to induce IFN expres-
sion. Finally, it will be intriguing to determine the role
of STING-dependent and AIM2-dependent signaling in
autoimmune diseases and to see if such pathways can
be targeted to improve DNA-based vaccine strategies
(see Fig. 1).
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